TABLE 4.
Diseases | Genes | Methylation status | References |
Stroke | CBS | Hyper | Wang et al., 2019 |
TM | Hyper | Yang Z. et al., 2016 | |
ApoE | Hyper | Zhang et al., 2019 | |
ABCG1 | Hyper | Qin et al., 2019 | |
CDKN2B | Hyper | Zhou et al., 2017 | |
PPM1A | Aberrant | Gallego-Fabrega et al., 2016a | |
TRAF3 | Hypo | Gallego-Fabrega et al., 2016b | |
LINE-1 | Hypo | Baccarelli et al., 2010 | |
MTRNR2L8 | Hypo | Shen et al., 2019 | |
AD | ApoE | Hyper | Rajan et al., 2015 |
ANK1 | Hyper | Lunnon et al., 2014 | |
RHBDF2 | Hyper | De Jager et al., 2014 | |
ABCA7 | Hyper | Yamazaki et al., 2017 | |
RPL13,CDH23 | Hyper | Prasad and Jho, 2019 | |
ANKRD30B | Hyper | Hua et al., 2019 |
AD, Alzheimer’s disease.